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The human CD4+FOXP3+ T cell population is heterogeneous and consists of various sub-
populations which remain poorly defined. Anergy and suppression are two main functional
characteristics of FOXP3+Treg cells. We used the anergic behavior of FOXP3+Treg cells
for a better discrimination and characterization of such subpopulations. We compared IL-2-
expressing with IL-2-non-expressing cells within the memory FOXP3+ T cell population. In
contrast to IL-2-non-expressing FOXP3+ cells, IL-2-expressing FOXP3+ cells exhibit inter-
mediate characteristics of Treg and Th cells concerning the Treg cell markers CD25, GITR,
and Helios. Besides lower levels of FOXP3, they also have higher levels of the transcrip-
tion factors NFATc2, c-Fos, NF-κBp65, and c-Jun. An approach combining flow cytometric
measurements with statistical interpretation for quantitative transcription factor analysis
suggests that the physiological expression levels not only of FOXP3 but also of NFATc2,
c-Jun, c-Fos, and NF-κBp65 are limiting for the decision whether IL-2 is expressed or not in
activated peripheral human memory FOXP3+ cells. These findings demonstrate that con-
comitant high levels of NFATc2, c-Jun, c-Fos, and NF-κBp65 lead in addition to potential
IL-2 expression in those FOXP3+ cells with low levels of FOXP3. We hypothesize that not
only the level of FOXP3 expression but also the amounts of the four transcription factors
studied represent determining factors for the anergic phenotype of FOXP3+ Treg cells.
Keywords: cytokine expression, transcription factors,T cell activation, IL-2 expression, lymphocyte, flow cytometry,
humanTreg cells, memoryTh cells
INTRODUCTION
FOXP3-expressing Treg cells are essential for the mainte-
nance of immunological self-tolerance and immune homeostasis.
CD4+FOXP3+ Treg cells are able to suppress the activation, pro-
liferation, and effector functions of many different immune cells
such as Th cells, cytotoxic T cells, NK cells, and APCs. These Treg
cells play a central role in preventing autoimmune diseases and
allergies as demonstrated in human diseases and animal mod-
els. Compared to murine FOXP3+ T cells, human FOXP3+ T
cells are more heterogeneous concerning their phenotypical and
functional properties resulting in various FOXP3+ subpopula-
tions (reviewed in Sakaguchi et al., 2010; Miyara and Sakaguchi,
2011). Furthermore, not all peripheral human CD4+FOXP3+
cells are suppressive (Baecher-Allan et al., 2001). This high com-
plexity of human FOXP3+ T cells causes some confusion in
the field. Therefore, many efforts were undertaken to discrim-
inate between suppressive and non-suppressive subpopulations
among the ex vivo isolated CD4+FOXP3+ human T cells. Most
promising so far is the division of FOXP3+ cells into three
subpopulations based on FOXP3 and CD45RA or CD45RO
expression: (i) naïve Treg cells (CD45RA+FOXP3low); (ii) mem-
ory effector Treg cells (CD45RA−FOXP3high); and (iii) mem-
ory non-suppressive Th cells (CD45RA−FOXP3low; Miyara et al.,
2009).
A detailed knowledge of human FOXP3+ cell subsets is essen-
tial for a better understanding of the regulation of human FOXP3
expression, the study of abnormalities among the FOXP3+ sub-
populations in autoimmune diseases and allergies, and the selec-
tion and purification of the most promising subpopulation(s) of
Treg cells for in vitro expansion and adoptive transfer (Fujii et al.,
2011; Miyara and Sakaguchi, 2011).
In this study we aimed at a better characterization
of human memory FOXP3-expressing T cell subpopulations
(CD4+CD45RO+FOXP3+) concerning anergy defined by the
inability to produce proinflammatory cytokines upon TCR/CD28
stimulation. Anergy and suppression are two main functional
characteristics of FOXP3+ Treg cells (Gavin et al., 2007; Wan and
Flavell, 2007; Williams and Rudensky, 2007). Therefore, we com-
pared IL-2-expressing and IL-2-non-expressing FOXP3+memory
T cells using Treg cell markers and the expression levels of five
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transcription factors. We used measurement of cytokine expres-
sion, in particular IL-2, by T cells as a substitute for suppression
assays, because it was hard to get enough pure cells after sorting of
the subpopulations. Performing a combination of flow cytometric
measurements with statistical analysis (Bendfeldt et al., 2012) we
studied the impact of low, medium low, medium high, and high
levels of the transcription factors FOXP3, NFATc2, c-Jun, c-Fos,
or NF-κBp65 on the decision whether IL-2 is expressed or not in
activated memory FOXP3+ cells. Results of our data analysis sug-
gest that low levels of FOXP3 expression in combination with high
levels of NFATc2, c-Jun, c-Fos, or NF-κBp65 are critically required
for IL-2 expression of FOXP3+ T cells.
MATERIALS AND METHODS
HUMAN T CELL ISOLATION, STIMULATION, AND STAINING
Peripheral blood mononuclear cells from healthy volunteers
were prepared using Ficoll PAQUE gradients from leukocyte
concentrates obtained from the blood bank of the red cross. Pos-
itively selected CD4+ cells were depleted of CD45RA+ Th cells
to a purity of >97% CD4+CD45RO+ memory Th cells (MACS
Separation Reagents; Miltenyi Biotech). After resting over night
cells were cultured in RPMI supplemented with 10% fetal calf
serum and stimulated either with 10 ng/ml PMA (Sigma) and
1µg/ml Ionomycin (Sigma) or with anti-CD3/CD28 antibody-
coupled beads (25µl per 1× 106 cells; Dynal Beads, Invitrogen).
Brefeldin A (Sigma) was added 30 min after stimulation to inhibit
IL-2 secretion and to trap the expressed IL-2 within the cells.
For cytometric analysis cells were stained for surface molecules
with anti-CD69-APC (Miltenyi) and anti-CD25-PE-Cy7 antibod-
ies (BD). For intracellular staining cells were fixed and perme-
abilized using the FOXP3 staining buffer set (eBioscience) and
stained with antibodies against FOXP3-FITC (eBioscience), IL-2-
APC (BD), IL-4-PE (BD), IL-17-PE (eBioscience), IFN-γ-Pacific
orange (own in-house antibody), NFATc2-FITC (own antibody,
BD), c-Fos-A488 (Santa Cruz Biotechnology), phospho-c-Jun-
A488 (Santa Cruz Biotechnology), NF-κBp65-A488 (Santa Cruz
Biotechnology), GITR-PE (Miltenyi), or Helios-PE (Biolegend).
Subsequently, cells were analyzed using a LSR II Fortessa (BD).
The MEK1/2 inhibitor U0126 (Biomol GmbH) was pre-incubated
with Th cells for 20 min before stimulation and was used in
concentrations of 0.01–250µM.
ISOLATION OF CD25−CD127+ CELLS BY FACS
Sorted CD4+CD45RO+ memory Th cells were stained with anti-
bodies against CD25-PE-Cy7 (BD) and CD127-PE (Beckman
Coulter) and sorted using a FACS Aria (BD).
DATA ANALYSIS AND MATHEMATICAL MODELING
The free software R was used for data analysis. Sorted memory
Th cells (CD4+CD45RO+) were gated for FOXP3 positive cells.
Quantification was performed by transforming the fluorescence
intensities of the cells into a linear scale using the asinh function.
The range of transcription factor expression levels was divided
either into four bins with equal cell numbers or into six bins
with equidistant expression levels resulting in uneven cell num-
ber distribution. For each bin the number of IL-2-producing cells
was calculated. Changes in mean expression levels were tested for
significance using a paired Student t -test.
Mathematical modeling was done using Matlab. For each
data set the parameters of the heuristic model were estimated
by minimizing the distance from the simulated data to the
experimental data (least square fitting). To compare models with
different number of parameters we used Akaike’s information cri-
terion with correction for finite sample sizes (AICc), which takes
into account the distance between model and data as well as con-
sidering the complexity of the model based on the number of
parameters.
RESULTS
UP TO ONE-FIFTH OF PERIPHERAL HUMANMEMORY FOXP3+ CELLS
ARE ABLE TO EXPRESS IL-2
Comparing transcription factor levels and cytokine expres-
sion within the memory CD4+ T cell population of healthy
donors (Bendfeldt et al., 2012) we discovered that there are
always 8–20% IL-2-expressing FOXP3+ Th cells, in spite of
the fact that FOXP3+ cells are widely considered to be inca-
pable of producing IL-2 and other effector cytokines (Hori
et al., 2003). The IL-2-expressing FOXP3+ cells were induced
by stimulation with PMA/ionomycin as well as with anti-
CD3/CD28 antibodies (Figure 1A). On the one hand, we con-
firmed that this population did not emerge from stimulation-
dependent up-regulation of FOXP3 in FOXP3− memory Th cells.
First, the frequency of FOXP3+ T cells did not change within
the studied time frame of 5 h after stimulation (Figure 1B).
Second, sorted memory Th cells (CD25−CD127+) that are
depleted of Treg cells (CD25highCD127low), did not up-regulate
FOXP3 expression after stimulation with PMA/ionomycin for
5 h (Figure 1C). On the other hand, staining of the activa-
tion marker CD69 demonstrated that all FOXP3+ T cells were
activated equally under the stimulation conditions employed
(Figure 1D).
We already knew that approximately 35% (+5%) of IL-2-
expressing activated memory Th cells are co-expressing IFN-γ
(Podtschaske et al., 2007 and data not shown). Here, we observed
similar frequencies of IFN-γ+ cells (approximately 30%) within
the IL-2+FOXP3+ cell population (data not shown). Among the
whole entity of FOXP3+ cells there were only low frequencies of
cells expressing IFN-γ (between 5 and 10%) and IL-17 as well as
IL-4 (both under 5%) after stimulation (Figure 1E).
IL-2-EXPRESSING FOXP3+ CELLS EXPRESS A LOWER LEVEL OF
PHENOTYPIC MARKERS OF TREG CELLS
To discover phenotypic differences between IL-2-non-expressing
and IL-2-expressing CD4+ FOXP3+ T cells we analyzed the levels
and frequencies of the Treg cell markers CD25, GITR, and Helios
in both subpopulations and compared them both with memory
Th cells (Figure 2). As expected IL-2− FOXP3+ cells express CD25,
GITR, and Helios (orange line), whereas all memory FOXP3− T
cells have a lower level of CD25 and GITR and were negative for
Helios (light and dark green lines). IL-2+ FOXP3+ showed an
intermediate expression level for CD25 and GITR and were nega-
tive for Helios expression (red line) indicating a cellular phenotype
between Treg and memory Th cells.
Specifically, to study whether Helios expression is dependent
on the level of FOXP3 per cell we divided the FOXP3 fluorescence
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FIGURE 1 | Activation-induced expression of IL-2 within the FOXP3+
memoryT cell population. Human CD4+CD45RO+ T cells were
isolated using magnetic cell-sorting. (A,B) Cells were stimulated with
PMA/ionomycin and antibodies against CD3/CD28 for 5 and 24 h,
respectively, and subsequently stained with fluorophore-coupled
antibodies and analyzed by flow cytometry. (C) CD4+CD45RO+ T cells
were stained with fluorophore-coupled antibodies against CD25 and
CD127. Subsequently CD25−CD127+ cells were sorted by FACS,
stimulated with PMA/ionomycin for 5 h, and subsequently fixed,
stained, and analyzed by flow cytometry. (D,E) PMA/ionomycin-
stimulated CD4+CD45RO+ T cells (5 h) were fixed, stained with
fluorophore-coupled antibodies, and analyzed by flow cytometry. Data
are representative out of two (C–E) or more than three (A,B)
independent experiments.
intensity (FI) of the IL-2−FOXP3+ subpopulation into quartiles.
Each quartile contained the same number of cells (Figure 2B, left).
Subsequently, the Helios expression in each quartile was plotted
into a histogram (Figure 2B, right). The level of FOXP3 per cell
showed a clear correlation with the number of Helios-expressing
FOXP3+ cells.
IL-2-EXPRESSING FOXP3+ CELLS EXPRESS MORE NFATc2 AND AP-1
BUT LESS FOXP3 THAN IL-2-NON-EXPRESSING FOXP3+ CELLS
Recently, we discovered that sorted human memory Treg cells
(CD25highCD127low) cells express lower levels of NFATc2, c-
Fos, NF-κBp65, and c-Jun than Treg-depleted memory Th cells
(CD25lowCD127high) by western blotting (Bendfeldt et al., 2012).
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FIGURE 2 | Phenotypical characterization of IL-2-expressing
FOXP3+ cells. Sorted human CD4+CD45RO+ T cells were stimulated
with PMA/ionomycin for 5 h and subsequently fixed, stained with
fluorophore-coupled antibodies, and analyzed by flow cytometry. (A)
Histograms show overlays of CD25, GITR, or Helios expression of
gated IL-2−FOXP3− (light green), IL-2+FOXP3− (dark green),
IL-2−FOXP3+ (orange), and IL-2+FOXP3+ cells (red). (B) Within the gated
FOXP3+ IL2− cell population, the range of FOXP3 expression level per
cell was divided into quartiles (with the same cell number). The effect
of the FOXP3 expression levels on Helios expression is shown in
histogram overlays. Results of one representative experiment are
shown (A,B: n=2).
These differences motivated us to examine whether the low
transcription factor expression observed in Treg cells is also
a general feature of IL-2-non-expressing, as compared with
IL-2-expressing, FOXP3+ cells.
Established co-stainings for IL-2 and the respective tran-
scription factors (Bendfeldt et al., 2012) enabled us to directly
compare quantitative differences in the expression levels of
NFATc2, c-Fos, NF-κBp65, p-c Jun, and c-Fos in IL-2+ and IL-2−
FOXP3+ cells (Figure 3, upper part). Flow cytometric analy-
sis of PMA/ionomycin-stimulated memory Th cells from five to
seven different donors showed a higher expression of NFATc2
(p= 0.0105), c-Fos (p= 0.0076), and p-c-Jun (p= 0.0197) in IL-
2-expressing than in IL-2-non-expressing FOXP3+ cells (Figure 3,
lower part). No significant differences were observed in the
expression of NF-κBp65 between IL-2+ and IL-2− FOXP3+ cells
(p= 0.9988). In order to stain c-Jun, we had to use a phospho-
specific antibody because co-staining of c-Jun together with IL-2
and FOXP3 was not possible so far. Interestingly, the expression
of FOXP3 was much lower (p= 0.0030) in IL-2+ than in IL-2−
FOXP3+ cells (n= 6; Figure 3). CD3/CD28-stimulated memory
Th cells showed similar results (data not shown).
Several reports revealed defects in the proximal TCR-signaling
cascade in FOXP3+ Th cells (Hickman et al., 2006; Carson and
Ziegler, 2007). Recently, we could rule out that these defects have
an impact on the activation of the main transcription factors at
strong stimulation, and therefore that they play a decisive role
for IL-2 expression in FOXP3+ T cells under these conditions
(Bendfeldt et al., 2012). Using co-staining and flow cytometric
measurement of nuclei we demonstrated that the activation of
NFATc2, c-Fos, and NF-κBp65 is unaffected after stimulation of
FOXP3+ cells, both with PMA/ionomycin and CD3/CD28 stim-
ulation. Therefore, the repression of IL-2 expression in FOXP3+
cells is not due to impaired activation of NFATc2, c-Fos, c-Jun, and
NF-κBp65.
LOW LEVELS OF FOXP3 AND HIGH LEVELS OF NFATc2, c-JUN, c-FOS,
AND NF-κBP65 ARE IMPORTANT FOR IL-2 DECISION MAKING IN
FOXP3+ CELLS
Testing the hypothesis that physiological levels of FOXP3 are lim-
iting for IL-2 expression in primary Treg cells usually requires
over-expression or knock-down of FOXP3. However, such manip-
ulations of primary Th cells often lead to a different status quo
not only of one transcription factor but also of the complete
transcription factor network compared to unmodified ex vivo cells.
Therefore, we decided to circumvent these difficulties, using
a novel approach combining flow cytometry data analysis with
statistical evaluation of single cell data. Within the FOXP3+
cell population of sorted and activated memory Th cells
(CD4+CD45RO+) of six healthy donors, we correlated the physi-
ological level of five transcription factors with IL-2 expression per
single cell. Specifically, for each transcription factor we divided the
FI, as a measure of the protein level per cell, into quartiles. Each
quartile contained the same number of cells (Figure 4, upper left).
Subsequently, the IL-2 expression in each quartile was plotted into
a histogram (Figure 4). The level of the four transcription factors
NFATc2, c-Fos, c-Jun, and NF-κBp65 showed an impressive corre-
lation with the number of IL-2-expressing FOXP3+ cells. This is in
contrast to the observed data concerning memory FOXP3− cells
where only c-Fos and to a lower amount NFATc2 but not c-Jun
and NF-κBp65 limit IL-2 expression (Bendfeldt et al., 2012).
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FIGURE 3 | Comparison of the transcription factor expression levels
between IL-2-expressing and -non-expressing FOXP3+ cells.
PMA/ionomycin-stimulated human CD4+CD45RO+ T cells were fixed,
stained with fluorophore-coupled antibodies, and analyzed by flow
cytometry. IL-2+ (black) and IL-2− (gray) FOXP3+ T cells were gated and
analyzed for the respective transcription factors. Displayed are histogram
overlays of the transcription factor expression in the two subpopulations of
one representative donor (n=5 or 6). Differences in the mean
fluorescence intensity (MFI) of the transcription factors between
IL-2-expressing and -non-expressing FOXP3+ Th cells in five or six different
donors are shown as graphs. Significance was determined using a paired
student t -test.
FOXP3 itself exhibits a clear negative correlation with the num-
ber of IL-2-producing FOXP3+ cells. As expected, quartiles with
higher levels of FOXP3 (yellow and ruby color) have lower num-
bers of IL-2-expressing cells. In contrast, quartiles with very low
(dark blue color) and relatively low (blue color) levels of FOXP3
per cell exhibit the highest numbers of IL-2 -expressing cells,
namely 28.7± 7.9 and 12.4± 8.0%, respectively (Figure 4, insets).
To verify that the level of the studied transcription factors
NFATc2, c-Jun, c-Fos, and NF-κBp65 correlates with IL-2 expres-
sion in FOXP3+ cells, we divided the FI of each transcription
factor into six bins and depicted the cell numbers as well as the
frequencies of IL-2 expression in each bin (Figure 5, lower part).
Obviously, the ratio of FOXP3 and the respective transcription fac-
tor is important for a high probability of IL-2 expression (arrows
are depicted in the bins with more than 30% IL-2-expressing
cells). Comparison of cell numbers of memory FOXP3+ with
FOXP3− cells (Figure 5, upper part) revealed that the whole pop-
ulation of FOXP3+ cells shifted to a lower level of transcription
factors, clearly visible for NFATc2, c-Fos, and NF-κBp65. Higher
cell numbers are in bins (darker bins) with a lower level of these
transcription factors. However, with this kind of studies we can-
not answer the question whether the reduced expression of these
transcription factors is a direct or indirect effect of FOXP3.
A minimal heuristic model estimates the balance of transcription
factors regulating IL-2 production in FOXP3+ cells
To better understand the underlying mechanisms of IL-2 expres-
sion in human memory FOXP3+ cells we combined our exper-
imental data with a minimal model of transcriptional regula-
tion.
Most models assume that the rate of transcription of a certain
gene is a function of the concentrations of the active transcription
factors. The cytokine IL-2, however, is expressed in an all-or-
none fashion (Podtschaske et al., 2007; Smith and Popmihajlov,
2008). Therefore, the level of IL-2 per cell remains constant after
successful activation. Consequently, we modeled the number of
IL-2-expressing cells instead of IL-2 expression level as a function
of transcription factor concentration.
To quantify the experimental findings, we used a heuris-
tic model with one activating variable x1 and one inhibiting
variable x2
y = f · x1 + b
1+ c1 · x1 + c2 · x2 , (1)
where b and f correspond to the basal and the maximal response
level, respectively. The parameters c1 and c2 reflect the effects of
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FIGURE 4 | Negative correlation of FOXP3 and positive correlation of
NFATc2, c-Fos, NF-κBp65, and c-Jun expression level with IL-2 expression
within the FOXP3+ population. Sorted human CD4+CD45RO+ T cells were
stimulated with PMA/ionomycin for 5 h, fixed and stained with
fluorophore-coupled antibodies against FOXP3, intracellular IL-2 and in parallel
with one of the transcription factors NFATc2, c-Fos, NF-κBp65, or p-c-Jun.
Data from the gated FOXP3+ cell population were transformed into a linear
scale using the asinh function. Subsequently, the range of transcription factor
expression level was divided into quartiles (with the same cell number)
according to the level of expression of each transcription factor at single cell
level (upper left). The effect of different transcription factor expression levels
on IL-2 expression is shown in histogram overlays of one experiment. The
inserts show the frequencies of IL-2-expressing FOXP3+ cells within the
quartiles from six different donors.
FIGURE 5 |The ratios of FOXP3 and NFATc2, c-Fos, NF-κBp65, or c-Jun
expression level are important for a high probability of IL-2 expression.
Sorting, stimulation, and staining of the cells were identical as described in
Figure 4. The range of the fluorescence intensity (FI) of each transcription
factor was divided into six bins. The cell numbers are depicted in a gray scale.
Arrows label the bins that exhibit more than 30% of IL-2-expressing cells.
the activating and the inhibiting transcription factors. The activat-
ing variable x1 represents the concentrations of the transcription
factors c-Fos, NFATc2, NF-κBp65, and p-c-Jun and the inhibit-
ing variable x2 corresponds to the concentration of FOXP3. The
dependent variable y reflects the fraction of cells that are able to
express IL-2 and therefore should be in the range between 0 and 1.
For simplicity, the parameters b (=0) and f (=1) were kept con-
stant, whereas c1 and c2 were estimated by minimizing the distance
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FIGURE 6 | Modeling confirms that NFATc2, c-Fos, c-Jun, and
NF-κBp65 have an activating effect on the frequency of
IL-2-expressing cells within the FOXP3+ population. Sorted human
Treg cells stimulated with PMA/ionomycin for 5 h were analyzed in
parallel for IL-2, FOXP3, and one activating transcription factor per cell by
flow cytometry. The normalized expression levels of the transcription
factors were divided into 2D-bins. The fraction of IL-2-expressing cells
was calculated for each bin, which contained at least five cells (black
diamonds). A heuristic model including an activating and an inhibiting
term was fitted to the data. The landscape of the model for each data
set (each TF from one donor) is superimposed on the data and the R2
value is shown.
from the simulated data to the experimental data (least square fit-
ting) for each combination of transcription factors available. The
explained variance R2 is a measure for the goodness of a fit and
describes the proportion of variability (or variance) of a data set,
which is accounted by a model. This simple model successfully
explains up to 55% of the variance of the data within one donor,
leaving the remaining variance open to experimental and techni-
cal noise. Relaxing the model constraints to allow f to be fitted as
well, leads to similar explained variance, but the Akaike’s value as
a measure of goodness of fit favors the two-parameter model.
The modeling confirms that the studied transcription factors
NFATc2, c-Fos, c-Jun, and NF-κBp65 have indeed an activating
effect on the frequency of IL-2-expressing cells within the FoxP3+
cell population. The model and corresponding data are shown in
Figure 6. Interestingly, the model predicts that the contribution
of all four activating transcription factors for IL-2 expression is
similar, because the fitted parameter c1 is comparable between
them.
MANIPULATION OF C-FOS EXPRESSION CONFIRMS THE CAUSAL
RELATIONSHIP BETWEEN THE LEVEL OF c-FOS AND THE PROBABILITY
OF IL-2 PRODUCTION PER CELL IN THE FOXP3+ POPULATION
In order to confirm that the transcription factor c-Fos is limit-
ing for IL-2 production, we manipulated the physiological c-Fos
expression levels using U0126, a specific MEK1/2 small molecular
inhibitor. Recently, we confirmed that U0126 does not inhibit the
expression of NFATc2, c-Jun, and NF-κBp65 under the conditions
used (Bendfeldt et al., 2012). U0126 inhibits de novo synthesis of c-
Fos after T cell stimulation in a dose-dependent manner (Figure 7,
upper part). Simultaneously, the frequency of IL-2 producers
declines in both, memory FOXP3− and FOXP3+ subpopulation
of sorted human CD4+ T cells (Figure 7, lower part).
DISCUSSION
A detailed knowledge of human FOXP3+ cell subsets is essential
for a better understanding of the regulation of human FOXP3
expression, the study of abnormalities among the FOXP3+ sub-
populations in autoimmune diseases and allergies, and the selec-
tion and purification of the most promising subpopulation(s) of
Treg cells for in vitro expansion and adoptive transfer (Fujii et al.,
2011; Miyara and Sakaguchi, 2011). Recent studies from different
groups have demonstrated the heterogeneity of human FOXP3+
cells and have begun to define and characterize possible subsets
(Baecher-Allan et al., 2001; Ito et al., 2008; Thornton et al., 2010;
Akimova et al., 2011; Bianchini et al., 2011; Schuler et al., 2011;
Solstad et al., 2011; Duhen et al., 2012).
In our studies, we depicted the IL-2-expressing cell sub-
set within the memory FOXP3+ population for further char-
acterization. Our procedure is based on the observation that
cytokine production (in particular IL-2 and IFN-γ) and sup-
pression are mutually exclusive functional programs within the
FOXP3+ T cell population (Gavin et al., 2007; Wan and Flavell,
2007; Williams and Rudensky, 2007). Therefore, we used mea-
surement of anergic behavior as a substitute for suppression
assays.
In agreement with others we found that up to 20% of all
memory FOXP3+ T cells (Miyara et al., 2009; Solstad et al.,
2011) and up to 35% of memory FOXP3low T cells express IL-
2 after stimulation. The present comparison of IL-2-expressing
vs. IL-2-non-expressing cell subsets of the memory FOXP3+
population revealed the following main phenotypical and func-
tional differences: IL-2-expressing memory FOXP3+ cells have
(i) lower levels of FOXP3, (ii) higher levels of NFATc2, c-Fos, c-
Jun, and NF-κBp65, (iii) lower levels of CD25 and GITR, and
(iv) almost no Helios expression. In contrast to memory Th
cells, IL-2 expression is not only limited by endogenous cellu-
lar amounts of c-Fos and NFATc2 but in addition by c-Jun and
NF-κBp65.
Due to the physiological importance and possible clinical
applications of human Treg cells, there have been many stud-
ies examining discrimination and characterization of differ-
ent subsets. So far, the most promising discrimination strategy
of human FOXP3+ Th cell subsets was proposed by Miyara
et al. (2009). The CD45RA−FOXP3low subset in particular
is still very heterogeneous concerning the phenotypical and
functional properties. The memory FOXP3low fraction reveals
intermediate characteristics of memory Treg and memory Th
cells.
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FIGURE 7 | Inhibition of c-Fos expression diminishes IL-2 expression
per cell in both, FOXP3− and FOXP3+ subpopulation. Sorted human
CD4+T cells were pre-incubated with different concentrations of the
MEK1/2 inhibitor U0126 for 20 min and subsequently stimulated with
PMA/ionomycin for 5 h. Gated memory Th cells (CD45RO+ CD45RA−) were
divided into FOXP3− and FOXP3+ cells for analyzing c-Fos and IL-2
expression in these two subpopulations. C-Fos expression and frequencies
of IL-2-expressing cells are depicted at different concentrations of U0126.
Shown are mean values and the standard deviation of two independent
experiments with three replicates each. Regression lines serve for guiding
the eye.
Why is it interesting to subdivide the memory FOXP3low popu-
lation into further subpopulations? On one hand, this population
is very large, comprising approximately 40% of the FOXP3+ cells
(Miyara et al., 2009). On the other hand this population might
contain both specific Th cells and specific Treg cells. The spe-
cific CD4+ T cells with low FOXP3 expression could be recently
activated Th cells (Gavin et al., 2006; Allan et al., 2007; Tran
et al., 2007; Wang et al., 2007). The specific memory Treg cells
with low FOXP3 expression could be exTreg (former Treg) cells,
as suggested by recent publications on murine Th cells (Miyao
et al., 2012). The activation-induced up-regulation of FOXP3
in ex vivo stimulated human Th cells seems to depend on the
strength of stimulation (Gavin et al., 2006; Allan et al., 2007;
Wang et al., 2007). ExTreg cells were recently identified in mice
(Miyao et al., 2012). These cells represent a minor population
of non-regulatory FOXP3+ cells losing FOXP3 expression but
retaining its memory. ExTreg cells are characterized by a lower
expression of certain Treg cell markers, such as FOXP3, CD25,
GITR, and Helios, and a higher frequency of IL-2- and IFN-γ-
expressing cells than those cells that retain a high FOXP3 expres-
sion. Approximately 30% of these exTreg cells regain FOXP3
expression in a TCR-dependent manner. Whether there are
human exTregs among the FOXP3low cell population has to be
studied.
However, irrespective of the suppressive capacities of “true”
FOXP3+Treg cells, FOXP3+CD25+ anergic T cells might play a
role in regulating Th cell proliferation, and differentiation anyway
by not producing IL-2 on the one side and consuming IL-2 on the
other side.
FOXP3 is neither a specific marker for human Treg cells
nor is it sufficient to induce stable Treg cells. Ectopic expres-
sion of both human FOXP3 isoforms in human CD4+ T cells
exhibited a profound suppression of IL-2 and IFN-γ produc-
tion and a partial up-regulation of several Treg cell-associated
markers. However, over-expression of FOXP3 did not lead to
acquisition of significant suppressor activity in vitro (Allan et al.,
2005). FOXP3 deletion (Gavin et al., 2007; Williams and Ruden-
sky, 2007) or reduction (Wan and Flavell, 2007) in mice par-
tially recovered the ability of IL-2 and IFN-γ production of Treg
cells.
FOXP3 is directly acting on several genes as a transcriptional
repressor or activator such as CD25 and CTLA-4, respectively. Our
recent data (Bendfeldt et al., 2012) and the present data illustrated
in Figures 3 and 5 suggest that the studied transcription factors
NFATc2, c-Fos, c-Jun, and NF-κBp65 are downregulated in the
FOXP3+ population. However, so far it is not known whether
these are direct or indirect effects of FOXP3. Interestingly, within
the memory FOXP3− population, only the endogenous level of
c-Fos and, to a lesser extent, NFATc2 are limiting for IL-2 expres-
sion (Bendfeldt et al., 2012). The transcription factors c-Jun and
NF-κBp65 occur in such physiological ranges that they do not
reduce the probability of IL-2 expression in memory Th cells.
This is in contrast to the memory FOXP3+ cells described here.
In these cells, not only are c-Fos and NFATc2 limiting for IL-2
expression but in addition c-Jun and NF-κBp65. We hypothe-
size that the concentration of c-Jun and NF-κBp65 shifted from
saturation for IL-2 expression in memory FOXP3− cells into a
region of limiting concentrations in memory FOXP3+ cells. All
our studies do not rule out the importance of other transcrip-
tion factors in the regulation of IL-2 expression such as c-Rel
or NFATc1 (Serfling et al., 1989; Randak et al., 1990; Briegel
et al., 1991; Hentsch et al., 1992; Kontgen et al., 1995; Rao et al.,
2003).
Computational models of transcriptional regulation combined
with comprehensive experimental data are helpful in understand-
ing the underlying molecular mechanisms of gene expression. In
the present report, we modeled the relation between transcrip-
tion factor concentration and the fraction of IL-2-expressing cells
Frontiers in Immunology | T Cell Biology August 2012 | Volume 3 | Article 264 | 8
Bendfeldt et al. IL-2 decision making in FOXP3+ T cells
based on a simple activation and inhibition form. Even with this
basic approach we were able to describe the experimental data very
well. More importantly, the estimated parameters are in a similar
range for each transcription factor, suggesting that their regulatory
strength is similar.
Altogether, our results indicate that human IL-2-expressing
compared to IL-2-non-expressing FOXP3+ cells exhibit a lower
level of phenotypical properties of Treg cells, a lower concen-
tration of FOXP3, and higher concentrations of NFATc2, c-Fos,
c-Jun, and NF-κBp65. We suggest that these two FOXP3+ cell
subsets behave also differently in vitro and in vivo. Therefore,
it is important to further characterize these two subpopulations
concerning their proliferative behavior and suppressive capacity
as well as in the context of autoimmune diseases (Miyara and
Sakaguchi, 2011), if it is possible to separate distinct phenotypic
subpopulations within the FOXP3low cell population in sufficient
amounts.
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